← Compounds
Adamax
peptide · headlineResearch use onlyUpregulates BDNF (brain-derived neurotrophic factor) expression in hippocampus and cortex
Summary
Adamax is a next-generation nootropic peptide and enhanced Semax analog featuring N-terminal acetylation and C-terminal adamantane modification for superior stability and blood-brain barrier penetration. It upregulates BDNF, enhances TrkB receptor sensitivity, modulates monoamines, and provides neuroprotection against oxidative stress and excitotoxicity.
How it works
- Upregulates BDNF (brain-derived neurotrophic factor) expression in hippocampus and cortex
- Enhances TrkB receptor sensitivity for improved neurotrophin signaling
- Modulates monoamine neurotransmitter levels (dopamine, norepinephrine, serotonin)
- Activates neuroprotective pathways reducing oxidative stress
- Stabilizes microtubules through ADNP-derived mechanisms
- Reduces excitotoxicity through neuromodulation
Dosing
- unit: mcglow dose: 300frequency: dailyhigh dose: 1000standard dose: 500administration route: Intranasal Spray
- unit: mcglow dose: 100frequency: dailyhigh dose: 500standard dose: 300administration route: Subcutaneous Injection
Cycling
- Can be used daily without cycling; however, some users rotate 5 days on / 2 days off to prevent tolerance development. Nasal mucosa health should be monitored during extended use.
- Daily administration recommended without cycling for cognitive support. Some protocols suggest 3 weeks on / 1 week off for tolerance management.
Side effects
common: ["Nasal irritation or congestion (intranasal administration)","Mild headache (usually transient)","Slight insomnia if dosed late in the day"]
warnings: ["May cause anxiety or overstimulation at high doses","Risk of sleep disruption if taken in evening","Limited long-term human safety data available"]
long term: ["Long-term safety profile unknown in humans","Extrapolated from Semax clinical experience only"]
Chemistry & PK
sequence: Ac-SEMAX-Adamantyl
half life: 2-4 hours (intranasal); 6-8 hours (subcutaneous)
degradation: Enzymatic degradation by serum proteases; slower degradation than native Semax due to adamantane modification.
molecular weight: 1568
molecular formula: C72H111N21O13
tissue specificity: CNS-specific distribution with high hippocampal, cortical, and striatal accumulation.
Used for
No condition evidence rows yet.
Legal / compounding
Research use only
Legal status is a hard gate: non-compoundable or delisted agents cannot be filled and are blocked from protocol export. Keep 503A status current.